Brief: Eledon Pharmaceuticals Reports Q1 Loss Per Share $0.57
May 13 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O :
* ELEDON PHARMACEUTICALS REPORTS FIRST QUARTER 2021
OPERATING AND
FINANCIAL RESULTS
* Q1 LOSS PER SHARE $0.57
* Q1 EARNINGS PER SHARE ESTIMATE $-0.32 -- REFINITIV IBES
DATA
* COMPANY HAD APPROXIMATELY $108.6 MILLION IN CASH AND CASH
EQUIVALENTS AS OF MARCH 31, 2021
* BELIEVES THAT IT HAS SUFFICIENT FINANCIAL RESOURCES TO
FUND
OPERATIONS AS CURRENTLY PLANNED WELL INTO 2023.
Source text for Eikon: ID:nGNX4Q7LdJ
Further company coverage: ELDN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial